Novartis CEO: Here Are 3 Things Big Pharma Must Do To Survive - 03 Apr 2013
After years of relative stability and high profits, things aren't looking particularly rosy for the pharmaceutical industry. Blockbuster drugs are losing patent protection, R&D efforts haven't paid off as hoped, and prices will come under pressure from the Affordable Care Act.
"We have to start building infrastructure now in sub-Saharan Africa, countries like Nigeria and Kenya, because those economies are growing at 6% to 7% per year. Their health care infrastructures are in their infancy," Jimenez says.
Read more: http://www.businessinsider.com/novartis-ceo-on-how-pharma-can-survive-2013-4#ixzz2PgGz6E3G